Third‐line systemic treatment for non‐small cell lung cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: In patients with advanced (Stage IIIB and IV) NSCLC with EGFR wild‐type, unknown status of EGFR, or with EGFR activating mutations (Mountain 1997), to assess in terms of OS and PFS the clinical efficacy of third‐...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Main Authors: Kim, Stefano C, Paget‐Bailly, Sophie, Trinquart, Ludovic, Calais, François, Bonnetain, Franck, Westeel, Virginie
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Ltd 2014
Assuntos:
Medicine General & Introductory Medical Sciences
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491211/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011291
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares